Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Arrowhead Pharma
(NQ:
ARWR
)
23.98
+1.07 (+4.67%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Arrowhead Pharma
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Arrowhead Pharmaceuticals to Participate in Upcoming October 2021 Conferences
September 29, 2021
From
Arrowhead Pharmaceuticals Inc.
Via
Business Wire
Arrowhead Earns $10 Million Phase 1 Milestone Payment
September 28, 2021
From
Arrowhead Pharmaceuticals Inc.
Via
Business Wire
Arrowhead Pharmaceuticals to Participate in Upcoming September 2021 Conferences
September 01, 2021
From
Arrowhead Pharmaceuticals Inc.
Via
Business Wire
Arrowhead Pharmaceuticals, inc (ARWR) Q3 2021 Earnings Call Transcript
August 06, 2021
ARWR earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Recap: Arrowhead Pharmaceuticals Q3 Earnings
August 05, 2021
Shares of Arrowhead Pharmaceuticals (NASDAQ:ARWR) were flat in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share were down 123.08%...
Via
Benzinga
Arrowhead Pharmaceuticals Reports Fiscal 2021 Third Quarter Results
August 05, 2021
From
Arrowhead Pharmaceuticals, Inc.
Via
Business Wire
Arrowhead Pharmaceuticals Receives Breakthrough Therapy Designation from U.S. FDA for ARO-AAT for the Treatment of Alpha-1 Antitrypsin Deficiency Associated Liver Disease
July 29, 2021
From
Arrowhead Pharmaceuticals, Inc.
Via
Business Wire
Arrowhead Pharmaceuticals: Buy the Dip?
July 19, 2021
This biotech underdog offers more than meets the eye.
Via
The Motley Fool
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Third Quarter Results
July 14, 2021
From
Arrowhead Pharmaceuticals Inc.
Via
Business Wire
Arrowhead Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
July 14, 2021
From
Arrowhead Pharmaceuticals, Inc.
Via
Business Wire
Russell 2000 Traders Place Bearish Bets Via IWM ETF
July 13, 2021
The iShares Russell 2000 ETF (NYSE: IWM) has been trading sideways for the better part of the last six months between $211 and its all-time high of $234.53 from March 15. IWM...
Via
Benzinga
Arrowhead's Big Sell-Off Presents Buying Opportunity, According to HC Wainwright
July 06, 2021
The sell-off on shares of Arrowhead Pharmaceuticals Inc (NASDAQ:
Via
Benzinga
Arrowhead's ARO-HIF2 Shows Early Signs Of Efficacy In Type Of Kidney Cancer
July 06, 2021
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) has announced interim results from the first two cohorts of Phase 1b study of ARO-HIF2 for clear cell renal cell...
Via
Benzinga
Arrowhead Announces Positive Interim Results from Phase 1b Study of ARO-HIF2 for Treatment of Clear Cell Renal Cell Carcinoma
July 06, 2021
From
Arrowhead Pharmaceuticals, Inc.
Via
Business Wire
Mid-Afternoon Market Update: Silver Rises 2%; Alector Shares Spike Higher
July 02, 2021
Toward the end of trading Friday, the Dow traded up 0.46% to 34,792.90 while the NASDAQ rose 0.67% to 14,619.12. The S&P also rose, gaining 0.66% to 4,348.47. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
S&P 500 Logs Another Record High as "Fear Gauge" Dips
July 02, 2021
Stocks are modestly in the black midday, thanks to upbeat monthly jobs data that showed 850,000 jobs were added in June.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
56 Biggest Movers From Friday
July 06, 2021
Gainers Sequential Brands Group, Inc. (NASDAQ: SQBG) jumped 89.2% to settle at $15.70. Eco Wave Power Global AB (NASDAQ: WAVE) shares surged 73.2% to close at $18.79. A 13G...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
July 02, 2021
Gainers Alector (NASDAQ:ALEC) shares moved upwards by 52.47% to $34.17 during Friday's regular session. Alector's stock is trading at a volume of 26.9 million...
Via
Benzinga
Arrowhead Stock Plunges, Alector Stock Surges On Drug News
July 02, 2021
Arrowhead paused a drug study; Alector teamed up with GlaxoSmithKline to develop two drugs. Arrowhead stock sank, while Alector stock surged.
Via
Investor's Business Daily
Mid-Day Market Update: Dow Surges Over 100 Points; Arrowhead Pharmaceuticals Shares Plummet
July 02, 2021
Midway through trading Friday, the Dow traded up 0.33% to 34,747.45 while the NASDAQ rose 0.50% to 14,594.85. The S&P also rose, gaining 0.47% to 4,340.12. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Here's Why Arrowhead Pharmaceuticals Stock Is Getting Hammered Today
July 02, 2021
A paused clinical trial with an important asset wasn't what investors wanted to hear today.
Via
The Motley Fool
12 Health Care Stocks Moving In Friday's Pre-Market Session
July 02, 2021
Gainers Alector (NASDAQ:ALEC) stock moved upwards by 39.93% to $31.36 during Friday's pre-market session. The market value of their outstanding shares is at $2.5...
Via
Benzinga
Arrowhead Stock Drops After RNAi Therapeutic Shows Lung Inflammation In Animal Models
July 02, 2021
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) has voluntarily paused the AROENaC1001 Phase 1/2 study evaluating ARO-ENaC for cystic fibrosis. ARO-ENaC is the...
Via
Benzinga
Arrowhead Pauses ARO-ENaC Phase 1/2 Clinical Study
July 02, 2021
From
Arrowhead Pharmaceuticals Inc.
Via
Business Wire
Arrowhead Pharmaceuticals Initiates Phase 2b Study of Investigational ARO-ANG3 for Treatment of Mixed Dyslipidemia
June 30, 2021
From
Arrowhead Pharmaceuticals Inc.
Via
Business Wire
Arrowhead Presents Additional Clinical Data on Investigational ARO-AAT Treatment in Patients with Alpha-1 Liver Disease at EASL International Liver Congress
June 26, 2021
From
Arrowhead Pharmaceuticals Inc.
Via
Business Wire
Arrowhead Presents Preclinical Data on ARO-DUX4 at FSHD Society International Research Congress
June 25, 2021
From
Arrowhead Pharmaceuticals, Inc.
Via
Business Wire
The Daily Biotech Pulse: Lilly Spikes On Alzheimer's Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO
June 24, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 23) AngioDynamics, Inc. (NASDAQ...
Via
Benzinga
Arrowhead Presents Positive Interim Clinical Data on ARO-HSD Treatment in Patients with Suspected NASH at EASL International Liver Congress
June 23, 2021
From
Arrowhead Pharmaceuticals Inc.
Via
Business Wire
Horizon Acquires Rights to Arrowhead's RNAi-Based Gout Treatment Candidate
June 21, 2021
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) and Horizon Therapeutics plc (NASDAQ: HZNP) have entered into a global collaboration and license agreement ...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.